RxDoctor Payments Data

Sarah Weber, NP

Family · Franklin, INNPI 1053932970

Payments from drug & device makers

$1,357in general payments, 2019–2025

Across 94 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$340
  • Lilly USA, LLC$246
  • AbbVie$200
  • Pfizer$70
  • AstraZeneca$51
  • Biohaven Pharmaceuticals, Inc.$49
  • plus $402 from 13 others

What the payments were for

  • Food & beverage$1,357100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,357 in reported general payments places this provider in the 70th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$24,106
Medicare patients
125
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,140
Albuterol Sulfate HfaAlbuterol Sulfate26$714
Dicyclomine Hcl12$621
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$493
Omeprazole28$351
Atorvastatin Calcium49$310
Levothyroxine Sodium55$308
Nystatin11$276
Gabapentin20$239
Amlodipine Besylate50$212
Simvastatin19$198
Cephalexin12$189
Venlafaxine Hcl ErVenlafaxine Hcl11$186
Metoprolol Succinate14$183
Metformin Hcl ErMetformin Hcl16$179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKAnoro Ellipta$44$5,14011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,392 family providers in Indiana.

Other family in Franklin

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →